New Jersey-based nutraceutical company Integrated Biopharma is spinning off its interest in iBioPharma to form a stand-alone biotech company. Chairman and CEO E. Gerald Kay said that iBioPharma will be able to raise capital and make pacts with other companies more effectively as a stand-alone than as a subsidiary of Integrated Biopharma. "We strongly believe in the long-term value of the propriety intellectual property developed and owned by iBioPharma, particularly in the growing area of vaccines and therapeutic proteins."
- check out this release